PRADAXA (dabigatran etexilate mesylate) Boehringer ingelheim Patent: 6,087,380 Expiration: Jun 28, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent …
Drug Patent Expirations for the Week of June 26, 2022 Read Post »
Annual Drug Patent Expirations for CAPRELSA Caprelsa is a drug marketed by Genzyme Corp and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent expiration for Genzyme Corp drug CAPRELSA appeared first…
New patent expiration for Genzyme Corp drug CAPRELSA Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Ireland. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical…
Which pharmaceutical companies have the most SPCs in Ireland? Read Post »
PRADAXA (dabigatran etexilate mesylate) Boehringer ingelheim Patent: 6,087,380 Expiration: Jun 28, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent …
Drug Patent Expirations for the Week of June 26, 2022 Read Post »
Annual Drug Patent Expirations for JUVISYNC Juvisync is a drug marketed by Merck Sharp Dohme and is included in one NDA. There are four patents protecting this drug and three…
The post New patent expiration for Merck Sharp drug JUVISYNC appeared first …
New patent expiration for Merck Sharp drug JUVISYNC Read Post »
This chart shows the pharmaceutical companies with the most suspension dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most suspension dosed drugs…
The post Which pharmaceutical companies have the mos…
Which pharmaceutical companies have the most suspension dosed drugs? Read Post »
Annual Drug Patent Expirations for ABILIFY+MAINTENA+KIT Abilify Maintena Kit is a drug marketed by Otsuka Pharm Co Ltd and is included in one NDA. It is available from one supplier.…
The post New patent for Otsuka Pharm drug ABILIFY MAINTENA KIT appear…
New patent for Otsuka Pharm drug ABILIFY MAINTENA KIT Read Post »
Annual Drug Patent Expirations for TIBSOVO Tibsovo is a drug marketed by Servier and is included in one NDA. There are eight patents protecting this drug. This drug has one…
The post New patent for Servier drug TIBSOVO appeared first on DrugPatentWatch…
Annual Drug Patent Expirations for TIBSOVO Tibsovo is a drug marketed by Servier and is included in one NDA. There are eight patents protecting this drug. This drug has one…
The post New patent for Servier drug TIBSOVO appeared first on DrugPatentWatch…
Annual Drug Patent Expirations for APTIOM Aptiom is a drug marketed by Sunovion Pharms Inc and is included in one NDA. It is available from one supplier. There are ten…
The post New patent for Sunovion Pharms drug APTIOM appeared first on DrugPatentWat…
Get new actionable insights and updates from BiotechBlog
